Aimee M Crago

7PUBLICATIONS
79CO-AUTHORS
Predictive and prognostic markersMolecular targetsChemotherapyPharmaceutical delivery technologiesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 30, 2026
Microsatellite Instability Identifies a Rare but Clinically Relevant Subset of Sarcomas: Insights from the Largest Clinically Sequenced Cohort with Therapeutic Implications.

|Jul 22, 2025
ctDNA as a Molecular Biomarker in the Phase II Trial of Imatinib plus Binimetinib in Patients with Advanced Gastrointestinal Stromal Tumor.

Ciara M Kelly, Martina Bradic, Sara Saunds

|Nov 09, 2023
PDGFRβ Signaling Cooperates with β-Catenin to Modulate c-Abl and Biologic Behavior of Desmoid-Type Fibromatosis.

Jia Hu, Meera R Hameed, Narasimhan P Agaram

|Sep 11, 2023
Therapy-Induced Senescence Contributes to the Efficacy of Abemaciclib in Patients with Dedifferentiated Liposarcoma.

Caroline E Gleason, Mark A Dickson, Mary E Klein Dooley

|Mar 27, 2023
A Phase II Study of Epacadostat and Pembrolizumab in Patients with Advanced Sarcoma.

Ciara M Kelly, Li-Xuan Qin, Karissa A Whiting

|Feb 03, 2022
A Phase Ib/II Randomized Study of RO4929097, a Gamma-Secretase or Notch Inhibitor with or without Vismodegib, a Hedgehog Inhibitor, in Advanced Sarcoma.

Mrinal M Gounder, Evan Rosenbaum, Nian Wu

Pageof 2

Frequent Collaborators

6 joint publications

William D Tap

5 joint publications

Cristina R Antonescu

4 joint publications

Samuel Singer

4 joint publications

Sandra P D'Angelo